MorphoSys AG Statistics
Total Valuation
MorphoSys AG has a market cap or net worth of $2.86 billion. The enterprise value is $4.09 billion.
| Market Cap | 2.86B |
| Enterprise Value | 4.09B |
Important Dates
The last earnings date was Thursday, August 29, 2024, after market close.
| Earnings Date | Aug 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MorphoSys AG has 150.65 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 150.65M |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 7.44% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 322.58 |
| PS Ratio | 10.79 |
| Forward PS | 16.06 |
| PB Ratio | 53.14 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 15.45 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.08, with a Debt / Equity ratio of 36.87.
| Current Ratio | 3.08 |
| Quick Ratio | 2.71 |
| Debt / Equity | 36.87 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.34 |
Financial Efficiency
Return on equity (ROE) is -183.80% and return on invested capital (ROIC) is -13.59%.
| Return on Equity (ROE) | -183.80% |
| Return on Assets (ROA) | -8.60% |
| Return on Capital (ROIC) | -13.59% |
| Revenue Per Employee | $505,255 |
| Profits Per Employee | -$402,320 |
| Employee Count | 524 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 1.28 |
Taxes
| Income Tax | -1.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +144.65% in the last 52 weeks. The beta is 0.67, so MorphoSys AG's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | +144.65% |
| 50-Day Moving Average | 18.42 |
| 200-Day Moving Average | 14.49 |
| Relative Strength Index (RSI) | 60.22 |
| Average Volume (20 Days) | 24,186 |
Short Selling Information
| Short Interest | 135,041 |
| Short Previous Month | 262,051 |
| Short % of Shares Out | 0.09% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.65 |
Income Statement
In the last 12 months, MorphoSys AG had revenue of $264.75 million and -$210.82 million in losses. Loss per share was -$1.52.
| Revenue | 264.75M |
| Gross Profit | 197.18M |
| Operating Income | -276.69M |
| Pretax Income | -209.23M |
| Net Income | -210.82M |
| EBITDA | -42.09M |
| EBIT | -53.64M |
| Loss Per Share | -$1.52 |
Balance Sheet
The company has $748.23 million in cash and $1.98 billion in debt, giving a net cash position of -$1.23 billion or -$8.19 per share.
| Cash & Cash Equivalents | 748.23M |
| Total Debt | 1.98B |
| Net Cash | -1.23B |
| Net Cash Per Share | -$8.19 |
| Equity (Book Value) | 53.75M |
| Book Value Per Share | 0.36 |
| Working Capital | 602.43M |
Cash Flow
In the last 12 months, operating cash flow was -$324.21 million and capital expenditures -$382,981, giving a free cash flow of -$324.59 million.
| Operating Cash Flow | -324.21M |
| Capital Expenditures | -382,981 |
| Free Cash Flow | -324.59M |
| FCF Per Share | -$2.36 |
Margins
Gross margin is 74.48%, with operating and profit margins of -104.51% and -79.63%.
| Gross Margin | 74.48% |
| Operating Margin | -104.51% |
| Pretax Margin | -79.03% |
| Profit Margin | -79.63% |
| EBITDA Margin | -15.90% |
| EBIT Margin | -20.26% |
| FCF Margin | -122.60% |
Dividends & Yields
MorphoSys AG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.46% |
| Shareholder Yield | -0.46% |
| Earnings Yield | -7.38% |
| FCF Yield | -11.36% |
Analyst Forecast
The average price target for MorphoSys AG is $12.13, which is -36.02% lower than the current price. The consensus rating is "Hold".
| Price Target | $12.13 |
| Price Target Difference | -36.02% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 33.94% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MorphoSys AG has an Altman Z-Score of 0.46 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.46 |
| Piotroski F-Score | 2 |